RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 22, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to...
At the fusion of fintech and medical research, Mural is modernizing the patient-trial connect Consistent participation of patients in clinical trials is...
Clinical trials receive a lot of oversight from regulatory agencies, as well as independent committees reviewing different aspects of the trial. Depending on the...
With recent studies from Oregon State University (OSU) raising essential points about drug safety and research transparency in an era when the U.S. Food...
NEW YORK, Aug. 9, 2023. Hoth Therapeutics, Inc. a patient-focused biopharmaceutical company, today announced that HT-ALZ, a therapeutic in development for the treatment of...
INDIANAPOLIS, Aug. 4, 2023. Eli Lilly and Company today announced topline results from the LIBRETTO-431 study evaluating Retevmo versus platinum-based chemotherapy plus pemetrexed –...
The first fixed dose combination (FDC) formulation containing dolutegravir that is suitable for certain paediatric HIV patients globally, has been deemed safe and effective...
